These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Should states adopt newborn screening for early infantile Krabbe disease? Dimmock DP Genet Med; 2016 Mar; 18(3):217-20. PubMed ID: 26845105 [TBL] [Abstract][Full Text] [Related]
10. The impact of false-positive newborn screening results on families: a qualitative study. Schmidt JL; Castellanos-Brown K; Childress S; Bonhomme N; Oktay JS; Terry SF; Kyler P; Davidoff A; Greene C Genet Med; 2012 Jan; 14(1):76-80. PubMed ID: 22237434 [TBL] [Abstract][Full Text] [Related]
11. Newborn screening for metabolic disorders: parental perceptions of the initial communication of results. Buchbinder M; Timmermans S Clin Pediatr (Phila); 2012 Aug; 51(8):739-44. PubMed ID: 22563060 [TBL] [Abstract][Full Text] [Related]
12. Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test. Tluczek A; Koscik RL; Modaff P; Pfeil D; Rock MJ; Farrell PM; Lifchez C; Freeman ME; Gershan W; Zaleski C; Sullivan B J Genet Couns; 2006 Aug; 15(4):277-91. PubMed ID: 16865559 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening: an appeal for improved parent education. Tluczek A; Orland KM; Nick SW; Brown RL J Perinat Neonatal Nurs; 2009; 23(4):326-34. PubMed ID: 19915416 [TBL] [Abstract][Full Text] [Related]
15. Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. Blom M; Bredius RGM; Jansen ME; Weijman G; Kemper EA; Vermont CL; Hollink IHIM; Dik WA; van Montfrans JM; van Gijn ME; Henriet SS; van Aerde KJ; Koole W; Lankester AC; Dekkers EHBM; Schielen PCJI; de Vries MC; Henneman L; van der Burg M; J Clin Immunol; 2021 Jan; 41(1):99-108. PubMed ID: 33070266 [TBL] [Abstract][Full Text] [Related]
16. Family Attitudes regarding Newborn Screening for Krabbe Disease: Results from a Survey of Leukodystrophy Registries. Blackwell K; Gelb MH; Grantham A; Spencer N; Webb C; West T Int J Neonatal Screen; 2020 Aug; 6(3):. PubMed ID: 33239592 [TBL] [Abstract][Full Text] [Related]
17. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Tluczek A; Koscik RL; Farrell PM; Rock MJ Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234 [TBL] [Abstract][Full Text] [Related]
18. Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease. Davids L; Sun Y; Moore RH; Lisi E; Wittenauer A; Wilcox WR; Ali N Mol Genet Metab; 2021; 134(1-2):20-28. PubMed ID: 34602357 [TBL] [Abstract][Full Text] [Related]
19. Pain points in parents' interactions with newborn screening systems: a qualitative study. Conway M; Vuong TT; Hart K; Rohrwasser A; Eilbeck K BMC Pediatr; 2022 Mar; 22(1):167. PubMed ID: 35361157 [TBL] [Abstract][Full Text] [Related]
20. Parental experiences of a diagnosis of neonatal diabetes and perceptions of newborn screening for glucose: a qualitative study. Shepherd M; Knight BA; Laskey K; McDonald TJ BMJ Open; 2020 Nov; 10(11):e037312. PubMed ID: 33148726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]